wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44756641-2326DFE3-0EC4-4F1E-AF79-EA3846432C03
Q44756641-2326DFE3-0EC4-4F1E-AF79-EA3846432C03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44756641-2326DFE3-0EC4-4F1E-AF79-EA3846432C03
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
P2860
Q44756641-2326DFE3-0EC4-4F1E-AF79-EA3846432C03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44756641-2326DFE3-0EC4-4F1E-AF79-EA3846432C03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afd7cadc774cee47949ae9733ab896a79a3b1e0f
P2860
M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.